My view point on Movano is simple. They have the resources to succeed with or without FDA approval or delay. They also have the intellectual resources to succeed as well in the industry they are endeavoring to break into. They have an excellent medical executive team. They have an excellent R&D staff. For them FDA approval would make their success easier to achieve. They are prepared to sell two product lines with approval and without approval.
Market Data 
Markets 
